Medicina (Jul 2019)

Comparative Outcomes of Respiratory Failure Associated with Common Neuromuscular Emergencies: Myasthenia Gravis versus Guillain–Barré Syndrome

  • Anantha R. Vellipuram,
  • Salvador Cruz-Flores,
  • Mohammad Rauf A. Chaudhry,
  • Prashanth Rawla,
  • Alberto Maud,
  • Gustavo J. Rodriguez,
  • Darine Kassar,
  • Paisith Piriyawat,
  • Mohtashim A. Qureshi,
  • Rakesh Khatri

DOI
https://doi.org/10.3390/medicina55070375
Journal volume & issue
Vol. 55, no. 7
p. 375

Abstract

Read online

Background and objectives: Myasthenia gravis (MG) and Guillain−Barré Syndrome (GBS) are autoimmune neuromuscular disorders that may present as neuromuscular emergencies requiring mechanical ventilation and critical care. Comparative outcomes of these disease processes, once severe enough to require mechanical ventilation, are not known. In this study, we compared the patients requiring mechanical ventilation in terms of in-hospital complications, length of stay, disability, and mortality between these two disease entities at a national level. Materials and Methods: Mechanically ventilated patients with primary diagnosis of MG (n = 6684) and GBS (n = 5834) were identified through retrospective analysis of Nationwide Inpatient Sample (NIS) database for the years 2006 to 2014. Results: Even though mechanically ventilated MG patients were older (61.0 ± 19.1 versus 54.9 ± 20.1 years) and presented with more medical comorbidities, they had lower disease severity on admission, as well as lower in-hospital complications sepsis, pneumonia, and urinary tract infections as compared with GBS patients. In the multivariate analysis, after adjusting for confounders including treatment, GBS patients had significantly higher disability (odds ratio (OR) 15.6, 95% confidence interval (CI) 10.9−22.2) and a longer length of stay (OR 3.48, 95% CI 2.22−5.48). There was no significant difference in mortality between the groups (8.45% MG vs. 10.0% GBS, p = 0.16). Conclusion: Mechanically ventilated GBS patients have higher disease severity at admission along with more in-hospital complications, length of stay, and disability compared with MG patients. Potential explanations for these findings include delay in the diagnosis, poor response to immunotherapy particularly in patients with axonal GBS variant, or longer recovery time after nerve damage.

Keywords